This company has been acquired
Surface Oncology Balance Sheet Health
Financial Health criteria checks 4/6
Surface Oncology has a total shareholder equity of $49.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $66.0M and $16.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.26m |
| Equity | US$49.18m |
| Total liabilities | US$16.83m |
| Total assets | US$66.01m |
Recent financial health updates
Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?
Feb 23
Is Surface Oncology (NASDAQ:SURF) A Risky Investment?
Nov 11Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?
Jun 07Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?
Feb 16
Recent updates
Forecast: Analysts Think Surface Oncology, Inc.'s (NASDAQ:SURF) Business Prospects Have Improved Drastically
Nov 07Analysts Just Made A Major Revision To Their Surface Oncology, Inc. (NASDAQ:SURF) Revenue Forecasts
Aug 08Surface Oncology GAAP EPS of -$0.46 misses by $0.01
Aug 03Surface Oncology: Neither Novartis, Nor GSK Or ARKG Is Able To Stop The Decline
May 25News Flash: Analysts Just Made A Dazzling Upgrade To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts
May 11Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?
Feb 23Surface Oncology: If Novartis, GlaxoSmithKline And ARK See Promise, So Do I
Jan 18Is Surface Oncology (NASDAQ:SURF) A Risky Investment?
Nov 11Surface Oncology: Staying The Course
Oct 24Surface Oncology: A Diverse, But Early Pipeline
Jul 13Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt?
Jun 07Surface Oncology EPS beats by $0.04, beats on revenue
May 05Here's What Surface Oncology, Inc.'s (NASDAQ:SURF) Shareholder Ownership Structure Looks Like
Mar 15Does Surface Oncology (NASDAQ:SURF) Have A Healthy Balance Sheet?
Feb 16Surface Oncology: Early Stage Cancer-Specific Company With Novel Assets
Dec 09What Kind Of Shareholders Hold The Majority In Surface Oncology, Inc.'s (NASDAQ:SURF) Shares?
Dec 08Surface Oncology shares rise 13% on Fast Track tag for SRF388
Nov 11Financial Position Analysis
Short Term Liabilities: SURF's short term assets ($60.6M) exceed its short term liabilities ($16.8M).
Long Term Liabilities: SURF has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SURF is debt free.
Reducing Debt: SURF had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SURF has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SURF has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15% each year